nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ABCG2—Topotecan—cervical cancer	0.421	0.634	CbGbCtD
Dexamethasone—ABCB1—Topotecan—cervical cancer	0.152	0.229	CbGbCtD
Dexamethasone—CYP3A4—Topotecan—cervical cancer	0.0909	0.137	CbGbCtD
Dexamethasone—PLA2G1B—exocrine gland—cervical cancer	0.0115	0.047	CbGeAlD
Dexamethasone—CYP19A1—semen—cervical cancer	0.0112	0.046	CbGeAlD
Dexamethasone—ANXA1—exocrine gland—cervical cancer	0.00879	0.0359	CbGeAlD
Dexamethasone—CYP4A11—renal system—cervical cancer	0.0056	0.0229	CbGeAlD
Dexamethasone—NR0B1—female reproductive system—cervical cancer	0.00521	0.0213	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—cervical cancer	0.005	0.0204	CbGeAlD
Dexamethasone—NR0B1—female gonad—cervical cancer	0.00474	0.0194	CbGeAlD
Dexamethasone—PLA2G1B—renal system—cervical cancer	0.00464	0.019	CbGeAlD
Dexamethasone—CYP4A11—vagina—cervical cancer	0.00405	0.0166	CbGeAlD
Dexamethasone—ANXA1—epithelium—cervical cancer	0.00382	0.0156	CbGeAlD
Dexamethasone—ANXA1—uterine cervix—cervical cancer	0.00379	0.0155	CbGeAlD
Dexamethasone—PLA2G1B—female reproductive system—cervical cancer	0.00371	0.0152	CbGeAlD
Dexamethasone—ANXA1—decidua—cervical cancer	0.00361	0.0148	CbGeAlD
Dexamethasone—ANXA1—renal system—cervical cancer	0.00355	0.0145	CbGeAlD
Dexamethasone—ANXA1—endometrium—cervical cancer	0.00343	0.014	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—cervical cancer	0.00338	0.0138	CbGeAlD
Dexamethasone—ANXA1—mammalian vulva—cervical cancer	0.00332	0.0136	CbGeAlD
Dexamethasone—CYP17A1—renal system—cervical cancer	0.00318	0.013	CbGeAlD
Dexamethasone—ANXA1—uterus—cervical cancer	0.00316	0.0129	CbGeAlD
Dexamethasone—CYP11A1—decidua—cervical cancer	0.00301	0.0123	CbGeAlD
Dexamethasone—ANXA1—female reproductive system—cervical cancer	0.00284	0.0116	CbGeAlD
Dexamethasone—ANXA1—female gonad—cervical cancer	0.00258	0.0106	CbGeAlD
Dexamethasone—ANXA1—vagina—cervical cancer	0.00257	0.0105	CbGeAlD
Dexamethasone—CYP17A1—female reproductive system—cervical cancer	0.00254	0.0104	CbGeAlD
Dexamethasone—NR3C2—uterine cervix—cervical cancer	0.00245	0.01	CbGeAlD
Dexamethasone—CYP11A1—female reproductive system—cervical cancer	0.00237	0.00968	CbGeAlD
Dexamethasone—CYP17A1—female gonad—cervical cancer	0.00232	0.00947	CbGeAlD
Dexamethasone—PGR—epithelium—cervical cancer	0.0023	0.00941	CbGeAlD
Dexamethasone—NR3C2—renal system—cervical cancer	0.0023	0.00939	CbGeAlD
Dexamethasone—PGR—uterine cervix—cervical cancer	0.00228	0.00933	CbGeAlD
Dexamethasone—NR3C2—endometrium—cervical cancer	0.00222	0.00908	CbGeAlD
Dexamethasone—PGR—decidua—cervical cancer	0.00217	0.00889	CbGeAlD
Dexamethasone—CYP11A1—female gonad—cervical cancer	0.00215	0.00881	CbGeAlD
Dexamethasone—NR3C2—mammalian vulva—cervical cancer	0.00215	0.00878	CbGeAlD
Dexamethasone—PGR—endometrium—cervical cancer	0.00206	0.00844	CbGeAlD
Dexamethasone—NR3C2—uterus—cervical cancer	0.00205	0.00836	CbGeAlD
Dexamethasone—SLCO1A2—renal system—cervical cancer	0.00197	0.00805	CbGeAlD
Dexamethasone—PGR—uterus—cervical cancer	0.0019	0.00777	CbGeAlD
Dexamethasone—CYP19A1—endometrium—cervical cancer	0.00186	0.00759	CbGeAlD
Dexamethasone—NR3C2—female reproductive system—cervical cancer	0.00184	0.00752	CbGeAlD
Dexamethasone—ABCC2—renal system—cervical cancer	0.00183	0.0075	CbGeAlD
Dexamethasone—CYP1B1—decidua—cervical cancer	0.00183	0.00748	CbGeAlD
Dexamethasone—CYP1B1—renal system—cervical cancer	0.0018	0.00734	CbGeAlD
Dexamethasone—CYP2A6—vagina—cervical cancer	0.00177	0.00726	CbGeAlD
Dexamethasone—CYP19A1—uterus—cervical cancer	0.00171	0.007	CbGeAlD
Dexamethasone—PGR—female reproductive system—cervical cancer	0.00171	0.00699	CbGeAlD
Dexamethasone—NR3C2—female gonad—cervical cancer	0.00167	0.00684	CbGeAlD
Dexamethasone—NR3C2—vagina—cervical cancer	0.00166	0.0068	CbGeAlD
Dexamethasone—ANXA1—lymph node—cervical cancer	0.00166	0.00679	CbGeAlD
Dexamethasone—CYP1B1—uterus—cervical cancer	0.0016	0.00654	CbGeAlD
Dexamethasone—PGR—female gonad—cervical cancer	0.00156	0.00636	CbGeAlD
Dexamethasone—PGR—vagina—cervical cancer	0.00155	0.00632	CbGeAlD
Dexamethasone—CYP19A1—female reproductive system—cervical cancer	0.00154	0.00629	CbGeAlD
Dexamethasone—CYP17A1—lymph node—cervical cancer	0.00149	0.00609	CbGeAlD
Dexamethasone—ABCC2—female reproductive system—cervical cancer	0.00147	0.006	CbGeAlD
Dexamethasone—CYP1B1—female reproductive system—cervical cancer	0.00144	0.00588	CbGeAlD
Dexamethasone—ABCG2—uterine cervix—cervical cancer	0.00143	0.00584	CbGeAlD
Dexamethasone—CYP19A1—female gonad—cervical cancer	0.0014	0.00572	CbGeAlD
Dexamethasone—CYP11A1—lymph node—cervical cancer	0.00138	0.00566	CbGeAlD
Dexamethasone—CYP2C8—renal system—cervical cancer	0.00138	0.00562	CbGeAlD
Dexamethasone—CYP1A1—epithelium—cervical cancer	0.00137	0.0056	CbGeAlD
Dexamethasone—ABCG2—decidua—cervical cancer	0.00136	0.00557	CbGeAlD
Dexamethasone—CYP1A1—uterine cervix—cervical cancer	0.00136	0.00555	CbGeAlD
Dexamethasone—CYP2C8—endometrium—cervical cancer	0.00133	0.00544	CbGeAlD
Dexamethasone—NR3C1—epithelium—cervical cancer	0.00133	0.00543	CbGeAlD
Dexamethasone—CYP3A5—uterine cervix—cervical cancer	0.00133	0.00542	CbGeAlD
Dexamethasone—NR3C1—uterine cervix—cervical cancer	0.00132	0.00538	CbGeAlD
Dexamethasone—CYP1B1—female gonad—cervical cancer	0.00131	0.00535	CbGeAlD
Dexamethasone—ABCG2—endometrium—cervical cancer	0.00129	0.00529	CbGeAlD
Dexamethasone—CYP1A1—renal system—cervical cancer	0.00127	0.00519	CbGeAlD
Dexamethasone—NR3C1—decidua—cervical cancer	0.00125	0.00513	CbGeAlD
Dexamethasone—ABCG2—mammalian vulva—cervical cancer	0.00125	0.00511	CbGeAlD
Dexamethasone—CYP3A5—renal system—cervical cancer	0.00124	0.00507	CbGeAlD
Dexamethasone—CYP2B6—renal system—cervical cancer	0.00123	0.00504	CbGeAlD
Dexamethasone—NR3C1—renal system—cervical cancer	0.00123	0.00504	CbGeAlD
Dexamethasone—ABCG2—uterus—cervical cancer	0.00119	0.00487	CbGeAlD
Dexamethasone—NR3C1—endometrium—cervical cancer	0.00119	0.00487	CbGeAlD
Dexamethasone—CYP1A1—mammalian vulva—cervical cancer	0.00119	0.00485	CbGeAlD
Dexamethasone—CYP2E1—renal system—cervical cancer	0.00116	0.00473	CbGeAlD
Dexamethasone—NR3C1—mammalian vulva—cervical cancer	0.00115	0.00471	CbGeAlD
Dexamethasone—PTGS2—epithelium—cervical cancer	0.00115	0.0047	CbGeAlD
Dexamethasone—CYP2C19—vagina—cervical cancer	0.00114	0.00467	CbGeAlD
Dexamethasone—PTGS2—uterine cervix—cervical cancer	0.00114	0.00466	CbGeAlD
Dexamethasone—CYP1A1—uterus—cervical cancer	0.00113	0.00462	CbGeAlD
Dexamethasone—CYP2C8—female reproductive system—cervical cancer	0.0011	0.0045	CbGeAlD
Dexamethasone—NR3C1—uterus—cervical cancer	0.0011	0.00449	CbGeAlD
Dexamethasone—NR3C2—lymph node—cervical cancer	0.00108	0.0044	CbGeAlD
Dexamethasone—PTGS2—renal system—cervical cancer	0.00107	0.00436	CbGeAlD
Dexamethasone—PTGS2—endometrium—cervical cancer	0.00103	0.00421	CbGeAlD
Dexamethasone—CYP1A1—female reproductive system—cervical cancer	0.00102	0.00416	CbGeAlD
Dexamethasone—PGR—lymph node—cervical cancer	0.001	0.00409	CbGeAlD
Dexamethasone—CYP2C8—vagina—cervical cancer	0.000996	0.00407	CbGeAlD
Dexamethasone—CYP2B6—female reproductive system—cervical cancer	0.000988	0.00404	CbGeAlD
Dexamethasone—NR3C1—female reproductive system—cervical cancer	0.000986	0.00403	CbGeAlD
Dexamethasone—CYP2C9—female reproductive system—cervical cancer	0.000978	0.004	CbGeAlD
Dexamethasone—ABCG2—female gonad—cervical cancer	0.000974	0.00398	CbGeAlD
Dexamethasone—ABCG2—vagina—cervical cancer	0.000968	0.00396	CbGeAlD
Dexamethasone—PTGS2—uterus—cervical cancer	0.00095	0.00388	CbGeAlD
Dexamethasone—CYP3A4—renal system—cervical cancer	0.000931	0.00381	CbGeAlD
Dexamethasone—CYP2E1—female reproductive system—cervical cancer	0.000927	0.00379	CbGeAlD
Dexamethasone—CYP1A1—female gonad—cervical cancer	0.000925	0.00378	CbGeAlD
Dexamethasone—CYP1A1—vagina—cervical cancer	0.000919	0.00376	CbGeAlD
Dexamethasone—CYP2D6—renal system—cervical cancer	0.000917	0.00375	CbGeAlD
Dexamethasone—CYP3A5—female gonad—cervical cancer	0.000904	0.0037	CbGeAlD
Dexamethasone—CYP19A1—lymph node—cervical cancer	0.0009	0.00368	CbGeAlD
Dexamethasone—CYP3A5—vagina—cervical cancer	0.000899	0.00368	CbGeAlD
Dexamethasone—NR3C1—female gonad—cervical cancer	0.000897	0.00367	CbGeAlD
Dexamethasone—CYP2B6—vagina—cervical cancer	0.000893	0.00365	CbGeAlD
Dexamethasone—NR3C1—vagina—cervical cancer	0.000892	0.00365	CbGeAlD
Dexamethasone—ABCC2—lymph node—cervical cancer	0.000859	0.00351	CbGeAlD
Dexamethasone—PTGS2—female reproductive system—cervical cancer	0.000854	0.00349	CbGeAlD
Dexamethasone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000854	0.00973	CbGpPWpGaD
Dexamethasone—NR3C1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000847	0.00965	CbGpPWpGaD
Dexamethasone—CYP1B1—lymph node—cervical cancer	0.000841	0.00344	CbGeAlD
Dexamethasone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000836	0.00953	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—UBE3A—cervical cancer	0.000828	0.00944	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—PIAS3—cervical cancer	0.00082	0.00934	CbGpPWpGaD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000814	0.00927	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000806	0.00918	CbGpPWpGaD
Dexamethasone—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.000805	0.00918	CbGpPWpGaD
Dexamethasone—NOS2—IL23-mediated signaling events—CD4—cervical cancer	0.000802	0.00914	CbGpPWpGaD
Dexamethasone—NOS2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000783	0.00892	CbGpPWpGaD
Dexamethasone—PTGS2—female gonad—cervical cancer	0.000777	0.00318	CbGeAlD
Dexamethasone—NOS2—Hemostasis—GP6—cervical cancer	0.000777	0.00885	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—SERPIND1—cervical cancer	0.000777	0.00885	CbGpPWpGaD
Dexamethasone—PTGS2—vagina—cervical cancer	0.000772	0.00316	CbGeAlD
Dexamethasone—ANXA1—GPCR ligand binding—TAAR6—cervical cancer	0.000763	0.00869	CbGpPWpGaD
Dexamethasone—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000759	0.00865	CbGpPWpGaD
Dexamethasone—CYP3A4—female reproductive system—cervical cancer	0.000746	0.00305	CbGeAlD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000739	0.00842	CbGpPWpGaD
Dexamethasone—CYP2D6—female reproductive system—cervical cancer	0.000734	0.003	CbGeAlD
Dexamethasone—ABCB1—epithelium—cervical cancer	0.000711	0.00291	CbGeAlD
Dexamethasone—ABCB1—uterine cervix—cervical cancer	0.000705	0.00288	CbGeAlD
Dexamethasone—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000693	0.0079	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—GP5—cervical cancer	0.000679	0.00774	CbGpPWpGaD
Dexamethasone—ABCB1—decidua—cervical cancer	0.000671	0.00275	CbGeAlD
Dexamethasone—CYP2D6—female gonad—cervical cancer	0.000668	0.00273	CbGeAlD
Dexamethasone—ABCB1—renal system—cervical cancer	0.000659	0.0027	CbGeAlD
Dexamethasone—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000656	0.00747	CbGpPWpGaD
Dexamethasone—ABCB1—endometrium—cervical cancer	0.000637	0.00261	CbGeAlD
Dexamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00063	0.00717	CbGpPWpGaD
Dexamethasone—ABCG2—lymph node—cervical cancer	0.000626	0.00256	CbGeAlD
Dexamethasone—NOS2—IL23-mediated signaling events—STAT3—cervical cancer	0.000621	0.00707	CbGpPWpGaD
Dexamethasone—ABCB1—mammalian vulva—cervical cancer	0.000617	0.00252	CbGeAlD
Dexamethasone—NOS2—AGE/RAGE pathway—CASP8—cervical cancer	0.000614	0.007	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—WNT2—cervical cancer	0.000595	0.00679	CbGpPWpGaD
Dexamethasone—CYP1A1—lymph node—cervical cancer	0.000595	0.00243	CbGeAlD
Dexamethasone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000588	0.0067	CbGpPWpGaD
Dexamethasone—ABCB1—uterus—cervical cancer	0.000587	0.0024	CbGeAlD
Dexamethasone—NR3C1—lymph node—cervical cancer	0.000577	0.00236	CbGeAlD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000569	0.00649	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000546	0.00622	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—MTOR—cervical cancer	0.000546	0.00622	CbGpPWpGaD
Dexamethasone—NR0B1—Generic Transcription Pathway—RARB—cervical cancer	0.000545	0.00621	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—CD4—cervical cancer	0.000544	0.00621	CbGpPWpGaD
Dexamethasone—ABCB1—female reproductive system—cervical cancer	0.000528	0.00216	CbGeAlD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000517	0.00589	CbGpPWpGaD
Dexamethasone—PTGS2—lymph node—cervical cancer	0.000499	0.00204	CbGeAlD
Dexamethasone—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000495	0.00564	CbGpPWpGaD
Dexamethasone—CYP19A1—FSH signaling pathway—MTOR—cervical cancer	0.000491	0.0056	CbGpPWpGaD
Dexamethasone—ABCB1—female gonad—cervical cancer	0.00048	0.00196	CbGeAlD
Dexamethasone—ABCB1—vagina—cervical cancer	0.000478	0.00195	CbGeAlD
Dexamethasone—NOS2—AGE/RAGE pathway—CASP3—cervical cancer	0.000465	0.0053	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—WNT5A—cervical cancer	0.000451	0.00514	CbGpPWpGaD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.000443	0.00505	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000436	0.00496	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—TAAR6—cervical cancer	0.000431	0.00491	CbGpPWpGaD
Dexamethasone—NOS2—IL12-mediated signaling events—STAT3—cervical cancer	0.000422	0.0048	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00042	0.00479	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—RARB—cervical cancer	0.000416	0.00474	CbGpPWpGaD
Dexamethasone—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000404	0.0046	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—TAAR6—cervical cancer	0.000391	0.00446	CbGpPWpGaD
Dexamethasone—NOS2—AGE/RAGE pathway—STAT3—cervical cancer	0.000391	0.00445	CbGpPWpGaD
Dexamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000388	0.00442	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—CASP3—cervical cancer	0.000387	0.00441	CbGpPWpGaD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.000386	0.0044	CbGpPWpGaD
Dexamethasone—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000374	0.00426	CbGpPWpGaD
Dexamethasone—NR0B1—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000361	0.00411	CbGpPWpGaD
Dexamethasone—NOS2—AGE/RAGE pathway—EGFR—cervical cancer	0.000355	0.00405	CbGpPWpGaD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.000351	0.004	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000348	0.00397	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000346	0.00394	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000336	0.00383	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000326	0.00371	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000318	0.00362	CbGpPWpGaD
Dexamethasone—ABCB1—lymph node—cervical cancer	0.000309	0.00126	CbGeAlD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000306	0.00349	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—WNT2—cervical cancer	0.000306	0.00348	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—EGFR—cervical cancer	0.000296	0.00337	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—AKAP13—cervical cancer	0.000295	0.00337	CbGpPWpGaD
Dexamethasone—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000295	0.00336	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—CASP3—cervical cancer	0.000292	0.00333	CbGpPWpGaD
Dexamethasone—Rash erythematous—Topotecan—cervical cancer	0.000292	0.0683	CcSEcCtD
Dexamethasone—NR3C1—Endoderm Differentiation—NOTCH1—cervical cancer	0.000276	0.00314	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000275	0.00314	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AKAP13—cervical cancer	0.000268	0.00306	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—FGFR3—cervical cancer	0.000267	0.00305	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000263	0.003	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—RARB—cervical cancer	0.000262	0.00299	CbGpPWpGaD
Dexamethasone—Extravasation—Topotecan—cervical cancer	0.000256	0.06	CcSEcCtD
Dexamethasone—CYP11A1—Corticotropin-releasing hormone—CASP3—cervical cancer	0.000256	0.00291	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000254	0.00289	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—RARB—cervical cancer	0.000253	0.00289	CbGpPWpGaD
Dexamethasone—ANXA1—Spinal Cord Injury—TP53—cervical cancer	0.000248	0.00283	CbGpPWpGaD
Dexamethasone—CYP11A1—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.000246	0.00281	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000243	0.00277	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000235	0.00268	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—HES1—cervical cancer	0.000234	0.00267	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—WNT5A—cervical cancer	0.000232	0.00264	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TAAR6—cervical cancer	0.000231	0.00264	CbGpPWpGaD
Dexamethasone—NR0B1—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000223	0.00254	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000223	0.00254	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—EGFR—cervical cancer	0.000223	0.00254	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000217	0.00247	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000217	0.00247	CbGpPWpGaD
Dexamethasone—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000216	0.00246	CbGpPWpGaD
Dexamethasone—Neuropathy—Topotecan—cervical cancer	0.00021	0.0491	CcSEcCtD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000204	0.00232	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000201	0.00229	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—RARB—cervical cancer	0.0002	0.00228	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CA9—cervical cancer	0.0002	0.00228	CbGpPWpGaD
Dexamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.0002	0.00228	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000198	0.00226	CbGpPWpGaD
Dexamethasone—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	0.000196	0.00224	CbGpPWpGaD
Dexamethasone—NOS2—Disease—WNT2—cervical cancer	0.000194	0.00222	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000188	0.00214	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—MTOR—cervical cancer	0.000188	0.00214	CbGpPWpGaD
Dexamethasone—NOS2—Spinal Cord Injury—TP53—cervical cancer	0.000187	0.00213	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.000184	0.0021	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000183	0.00209	CbGpPWpGaD
Dexamethasone—NR3C1—Endoderm Differentiation—CTNNB1—cervical cancer	0.000183	0.00209	CbGpPWpGaD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000183	0.00209	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—WNT2—cervical cancer	0.000181	0.00206	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—CTNNB1—cervical cancer	0.000179	0.00204	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000176	0.00201	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—NOTCH2—cervical cancer	0.000174	0.00198	CbGpPWpGaD
Dexamethasone—NR3C2—Generic Transcription Pathway—NOTCH1—cervical cancer	0.00017	0.00194	CbGpPWpGaD
Dexamethasone—Dermatitis bullous—Topotecan—cervical cancer	0.00017	0.0397	CcSEcCtD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000169	0.00192	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000168	0.00191	CbGpPWpGaD
Dexamethasone—Anaphylactoid reaction—Topotecan—cervical cancer	0.000168	0.0392	CcSEcCtD
Dexamethasone—Lethargy—Topotecan—cervical cancer	0.000166	0.0387	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—AKAP13—cervical cancer	0.000158	0.00181	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000158	0.0018	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CA9—cervical cancer	0.000158	0.0018	CbGpPWpGaD
Dexamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000157	0.00179	CbGpPWpGaD
Dexamethasone—Cardiac arrest—Topotecan—cervical cancer	0.000154	0.0361	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000151	0.00172	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00015	0.00171	CbGpPWpGaD
Dexamethasone—NOS2—Disease—WNT5A—cervical cancer	0.000147	0.00168	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—RARB—cervical cancer	0.000146	0.00167	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—WNT5A—cervical cancer	0.000137	0.00156	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000134	0.00152	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000134	0.00152	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—NOTCH2—cervical cancer	0.000133	0.00151	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.000132	0.00151	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—EGFR—cervical cancer	0.000132	0.0015	CbGpPWpGaD
Dexamethasone—Weight increased—Topotecan—cervical cancer	0.000128	0.0299	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—TAAR6—cervical cancer	0.000126	0.00144	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000124	0.00141	CbGpPWpGaD
Dexamethasone—Neuropathy peripheral—Topotecan—cervical cancer	0.000123	0.0287	CcSEcCtD
Dexamethasone—NOS2—Circadian rythm related genes—TP53—cervical cancer	0.000122	0.00139	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—RARB—cervical cancer	0.000122	0.00139	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CA9—cervical cancer	0.000121	0.00137	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.00012	0.00136	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—TP53—cervical cancer	0.000119	0.00136	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000114	0.0013	CbGpPWpGaD
Dexamethasone—Haemoglobin—Topotecan—cervical cancer	0.000113	0.0264	CcSEcCtD
Dexamethasone—Haemorrhage—Topotecan—cervical cancer	0.000112	0.0263	CcSEcCtD
Dexamethasone—CYP11A1—Metabolism—CA9—cervical cancer	0.00011	0.00126	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.00011	0.00125	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CA9—cervical cancer	0.000109	0.00124	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—CTNNB1—cervical cancer	0.000109	0.00124	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—NOTCH1—cervical cancer	0.000108	0.00123	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—cervical cancer	0.000105	0.0012	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000104	0.00118	CbGpPWpGaD
Dexamethasone—Angiopathy—Topotecan—cervical cancer	0.000102	0.0238	CcSEcCtD
Dexamethasone—Alopecia—Topotecan—cervical cancer	9.91e-05	0.0232	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—WNT2—cervical cancer	9.87e-05	0.00112	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CASP3—cervical cancer	9.79e-05	0.00112	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—NOTCH2—cervical cancer	9.69e-05	0.0011	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CA9—cervical cancer	9.69e-05	0.0011	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NOTCH2—cervical cancer	9.6e-05	0.00109	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—STAT3—cervical cancer	9.52e-05	0.00108	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	9.44e-05	0.00108	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	9.27e-05	0.00106	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CASP3—cervical cancer	9.06e-05	0.00103	CbGpPWpGaD
Dexamethasone—Ill-defined disorder—Topotecan—cervical cancer	9.06e-05	0.0212	CcSEcCtD
Dexamethasone—Angioedema—Topotecan—cervical cancer	8.92e-05	0.0209	CcSEcCtD
Dexamethasone—Malaise—Topotecan—cervical cancer	8.81e-05	0.0206	CcSEcCtD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	8.7e-05	0.000992	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKAP13—cervical cancer	8.67e-05	0.000987	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HES1—cervical cancer	8.48e-05	0.000966	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	8.34e-05	0.00095	CbGpPWpGaD
Dexamethasone—Myalgia—Topotecan—cervical cancer	8.32e-05	0.0195	CcSEcCtD
Dexamethasone—Discomfort—Topotecan—cervical cancer	8.22e-05	0.0192	CcSEcCtD
Dexamethasone—NR3C2—Gene Expression—NOTCH1—cervical cancer	8.21e-05	0.000935	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—MTHFR—cervical cancer	8.12e-05	0.000925	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CA9—cervical cancer	8.09e-05	0.000921	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—NOTCH2—cervical cancer	8.07e-05	0.00092	CbGpPWpGaD
Dexamethasone—Anaphylactic shock—Topotecan—cervical cancer	7.97e-05	0.0187	CcSEcCtD
Dexamethasone—Infection—Topotecan—cervical cancer	7.92e-05	0.0185	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—HES1—cervical cancer	7.87e-05	0.000897	CbGpPWpGaD
Dexamethasone—Nervous system disorder—Topotecan—cervical cancer	7.82e-05	0.0183	CcSEcCtD
Dexamethasone—Thrombocytopenia—Topotecan—cervical cancer	7.8e-05	0.0183	CcSEcCtD
Dexamethasone—Hyperhidrosis—Topotecan—cervical cancer	7.71e-05	0.018	CcSEcCtD
Dexamethasone—Anorexia—Topotecan—cervical cancer	7.6e-05	0.0178	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—WNT5A—cervical cancer	7.48e-05	0.000852	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MTHFR—cervical cancer	7.45e-05	0.000849	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TERT—cervical cancer	7.43e-05	0.000847	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CA9—cervical cancer	7.31e-05	0.000833	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—cervical cancer	7.31e-05	0.000833	CbGpPWpGaD
Dexamethasone—Musculoskeletal discomfort—Topotecan—cervical cancer	7.26e-05	0.017	CcSEcCtD
Dexamethasone—Paraesthesia—Topotecan—cervical cancer	7.16e-05	0.0168	CcSEcCtD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	7.08e-05	0.000807	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—RARB—cervical cancer	7.05e-05	0.000803	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CA9—cervical cancer	7.04e-05	0.000802	CbGpPWpGaD
Dexamethasone—Dyspepsia—Topotecan—cervical cancer	7.02e-05	0.0164	CcSEcCtD
Dexamethasone—Decreased appetite—Topotecan—cervical cancer	6.93e-05	0.0162	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—TERT—cervical cancer	6.9e-05	0.000786	CbGpPWpGaD
Dexamethasone—Gastrointestinal disorder—Topotecan—cervical cancer	6.88e-05	0.0161	CcSEcCtD
Dexamethasone—Fatigue—Topotecan—cervical cancer	6.87e-05	0.0161	CcSEcCtD
Dexamethasone—NOS2—Disease—FGFR3—cervical cancer	6.82e-05	0.000777	CbGpPWpGaD
Dexamethasone—Pain—Topotecan—cervical cancer	6.82e-05	0.016	CcSEcCtD
Dexamethasone—Feeling abnormal—Topotecan—cervical cancer	6.57e-05	0.0154	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Topotecan—cervical cancer	6.52e-05	0.0153	CcSEcCtD
Dexamethasone—ABCG2—Metabolism—CA9—cervical cancer	6.4e-05	0.00073	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NOTCH1—cervical cancer	6.4e-05	0.00073	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—MTHFR—cervical cancer	6.39e-05	0.000729	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CA9—cervical cancer	6.35e-05	0.000723	CbGpPWpGaD
Dexamethasone—Urticaria—Topotecan—cervical cancer	6.33e-05	0.0148	CcSEcCtD
Dexamethasone—ANXA1—Signaling Pathways—FGFR3—cervical cancer	6.33e-05	0.000721	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	6.31e-05	0.000719	CbGpPWpGaD
Dexamethasone—Abdominal pain—Topotecan—cervical cancer	6.3e-05	0.0148	CcSEcCtD
Dexamethasone—Body temperature increased—Topotecan—cervical cancer	6.3e-05	0.0148	CcSEcCtD
Dexamethasone—PTGS2—Disease—WNT2—cervical cancer	6.17e-05	0.000704	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	6.08e-05	0.000693	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—cervical cancer	6e-05	0.000684	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—cervical cancer	5.95e-05	0.000678	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NOTCH1—cervical cancer	5.94e-05	0.000677	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.91e-05	0.000674	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—cervical cancer	5.84e-05	0.000666	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CA9—cervical cancer	5.82e-05	0.000663	CbGpPWpGaD
Dexamethasone—Asthenia—Topotecan—cervical cancer	5.72e-05	0.0134	CcSEcCtD
Dexamethasone—Pruritus—Topotecan—cervical cancer	5.64e-05	0.0132	CcSEcCtD
Dexamethasone—Diarrhoea—Topotecan—cervical cancer	5.45e-05	0.0128	CcSEcCtD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—cervical cancer	5.3e-05	0.000603	CbGpPWpGaD
Dexamethasone—Dizziness—Topotecan—cervical cancer	5.27e-05	0.0123	CcSEcCtD
Dexamethasone—PGR—Signaling Pathways—NOTCH2—cervical cancer	5.25e-05	0.000598	CbGpPWpGaD
Dexamethasone—Vomiting—Topotecan—cervical cancer	5.07e-05	0.0119	CcSEcCtD
Dexamethasone—Rash—Topotecan—cervical cancer	5.03e-05	0.0118	CcSEcCtD
Dexamethasone—Dermatitis—Topotecan—cervical cancer	5.02e-05	0.0118	CcSEcCtD
Dexamethasone—PGR—Gene Expression—NOTCH1—cervical cancer	5e-05	0.00057	CbGpPWpGaD
Dexamethasone—Headache—Topotecan—cervical cancer	4.99e-05	0.0117	CcSEcCtD
Dexamethasone—CYP17A1—Metabolism—MTHFR—cervical cancer	4.89e-05	0.000558	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CA9—cervical cancer	4.88e-05	0.000556	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	4.82e-05	0.000549	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MTOR—cervical cancer	4.8e-05	0.000547	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CD4—cervical cancer	4.79e-05	0.000546	CbGpPWpGaD
Dexamethasone—Nausea—Topotecan—cervical cancer	4.73e-05	0.0111	CcSEcCtD
Dexamethasone—CYP2B6—Metabolism—CA9—cervical cancer	4.69e-05	0.000535	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—WNT5A—cervical cancer	4.68e-05	0.000533	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NOTCH2—cervical cancer	4.67e-05	0.000532	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CA9—cervical cancer	4.6e-05	0.000524	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CA9—cervical cancer	4.59e-05	0.000523	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—MTHFR—cervical cancer	4.48e-05	0.00051	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.47e-05	0.00051	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MTOR—cervical cancer	4.45e-05	0.000508	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—MTHFR—cervical cancer	4.43e-05	0.000505	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CA9—cervical cancer	4.33e-05	0.000494	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.31e-05	0.000491	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HES1—cervical cancer	4.3e-05	0.000491	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CTNNB1—cervical cancer	4.25e-05	0.000485	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CASP3—cervical cancer	4.1e-05	0.000467	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.05e-05	0.000461	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CA9—cervical cancer	3.97e-05	0.000453	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CTNNB1—cervical cancer	3.95e-05	0.00045	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—MTHFR—cervical cancer	3.93e-05	0.000448	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TERT—cervical cancer	3.77e-05	0.00043	CbGpPWpGaD
Dexamethasone—NOS2—Disease—STAT3—cervical cancer	3.71e-05	0.000422	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CA9—cervical cancer	3.55e-05	0.000404	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CA9—cervical cancer	3.46e-05	0.000394	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—FGFR3—cervical cancer	3.46e-05	0.000394	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—STAT3—cervical cancer	3.44e-05	0.000392	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.42e-05	0.000389	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—cervical cancer	3.37e-05	0.000384	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—MTHFR—cervical cancer	3.28e-05	0.000374	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CA9—cervical cancer	3.26e-05	0.000372	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NOTCH1—cervical cancer	3.25e-05	0.00037	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CA9—cervical cancer	3.23e-05	0.000369	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—cervical cancer	3.13e-05	0.000356	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MTHFR—cervical cancer	2.97e-05	0.000338	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NOTCH1—cervical cancer	2.89e-05	0.000329	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.87e-05	0.000327	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MTHFR—cervical cancer	2.86e-05	0.000325	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HES1—cervical cancer	2.69e-05	0.000307	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—cervical cancer	2.63e-05	0.000299	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MTHFR—cervical cancer	2.6e-05	0.000296	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MTHFR—cervical cancer	2.58e-05	0.000293	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MTOR—cervical cancer	2.43e-05	0.000277	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTHFR—cervical cancer	2.37e-05	0.00027	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MTHFR—cervical cancer	2.36e-05	0.000269	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TERT—cervical cancer	2.36e-05	0.000269	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—cervical cancer	2.24e-05	0.000255	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGFR3—cervical cancer	2.17e-05	0.000247	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—cervical cancer	2.16e-05	0.000246	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CA9—cervical cancer	2.13e-05	0.000243	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOTCH1—cervical cancer	2.03e-05	0.000232	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTHFR—cervical cancer	1.98e-05	0.000226	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTHFR—cervical cancer	1.9e-05	0.000217	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—cervical cancer	1.88e-05	0.000214	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTHFR—cervical cancer	1.87e-05	0.000213	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—cervical cancer	1.86e-05	0.000212	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—cervical cancer	1.76e-05	0.0002	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—cervical cancer	1.71e-05	0.000195	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—cervical cancer	1.61e-05	0.000184	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTOR—cervical cancer	1.52e-05	0.000174	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—cervical cancer	1.52e-05	0.000173	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—cervical cancer	1.44e-05	0.000164	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—cervical cancer	1.44e-05	0.000164	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—cervical cancer	1.4e-05	0.00016	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—cervical cancer	1.35e-05	0.000154	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—cervical cancer	1.32e-05	0.000151	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—cervical cancer	1.31e-05	0.00015	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—cervical cancer	1.18e-05	0.000134	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—cervical cancer	1.07e-05	0.000122	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—cervical cancer	8.65e-06	9.86e-05	CbGpPWpGaD
